摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-硝基-正(1-苯乙基)苯甲酰胺 | 124264-90-0

中文名称
2-硝基-正(1-苯乙基)苯甲酰胺
中文别名
——
英文名称
2-nitro-N-(1-phenylethyl)benzamide
英文别名
2-Nitro-benzoesaeure-<1-phenyl-aethylamid>
2-硝基-正(1-苯乙基)苯甲酰胺化学式
CAS
124264-90-0
化学式
C15H14N2O3
mdl
——
分子量
270.288
InChiKey
TYMCJGBVKJRKCM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    161.5-162 °C
  • 沸点:
    463.6±38.0 °C(Predicted)
  • 密度:
    1.230±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    74.9
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2924299090

SDS

SDS:ff755160fdf10fabf5b9964fcba7c30d
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Nitro-N-(1-phenylethyl)benzamide
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Nitro-N-(1-phenylethyl)benzamide
CAS number: 124264-90-0

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C15H14N2O3
Molecular weight: 270.3

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-硝基-正(1-苯乙基)苯甲酰胺 在 palladium on activated charcoal 氢气 作用下, 生成 2-氨基-N-(1-苯乙基)-苯甲酰胺
    参考文献:
    名称:
    Sirtuin Inhibiting Compounds
    摘要:
    本文提供了治疗或预防癌症和自身免疫疾病的组合物和方法。组合物包括抑制sirtuin的化合物,降低sirtuin的活性,如SIRT1或Sir2。示例方法包括将细胞或分子与抑制sirtuin的化合物接触,降低sirtuin的活性,从而缩短细胞的寿命,杀死细胞或使其对包括放射治疗和化疗在内的某些细胞应激变得敏感。其他方法包括治疗表达sirtuin的病原体。
    公开号:
    US20090137681A1
  • 作为产物:
    描述:
    苏合香醇2-硝基苯甲腈1-丙基磷酸酐 作用下, 以 乙酸乙酯 为溶剂, 反应 3.0h, 以90%的产率得到2-硝基-正(1-苯乙基)苯甲酰胺
    参考文献:
    名称:
    在无溶剂条件下使用丙基膦酸酐 (T3P®) 从腈和醇合成 N-取代酰胺的创新方法
    摘要:
    摘要 使用丙基膦酸酐 (T3P®) 从腈和醇中开发了构建 N-取代酰胺衍生物的新型便捷方法。该方法是通过 Ritter 反应合成酰胺的另一种方法,这是从腈和醇合成 N-取代酰胺的经典方法之一。在这种方法中,首先 T3P® 激活醇,然后被腈攻击形成 N-取代酰胺。该方法也适用于二苯甲基醚的合成。这个开发的协议是 T3P® 的新应用之一。图形概要
    DOI:
    10.1080/00397911.2019.1616761
点击查看最新优质反应信息

文献信息

  • [EN] SIRTUIN INHIBITING COMPOUNDS<br/>[FR] COMPOSÉS INHIBANT LA SIRTUINE
    申请人:HARVARD COLLEGE
    公开号:WO2007084162A2
    公开(公告)日:2007-07-26
    [EN] Provided herein are compositions and methods for treating or preventing cancer and autoimmune diseases. Compositions comprise a sirtuin inhibitory compound that decreases the activity of a sirtuin, such as SIRTl or Sir2. Exemplary methods comprise contacting a cell or a molecule with a sirtuin inhibitory compound that decreases the activity of a sirtuin and thereby reduces the life span of a cell, kills the cell or renders it suspectible to certain cell stresses including radiation and chemotherapy. Other methods include treating pathogens expressing a sirtuin.
    [FR] La présente invention concerne des compositions et des procédés de traitement et de prévention du cancer et de maladies autoimmunes. Ces compositions comprennent un composé inhibiteur de sirtuine qui diminue l'activité d'une sirtuine, telle que SIRTI ou Dir2. Des procédés de l'invention consistent à mettre en contact une cellule ou une molécule avec un composé inhibiteur de sirtuine qui diminue l'activité d'une sirtuine, réduisant ainsi la durée de vie d'une cellule, tuant la cellule ou la rendant sensible à certains stress cellulaires, notamment au rayons et à la chimiothérapie. D'autres procédés consistent à traiter des pathogènes exprimant une sirtuine.
  • Innovative approach for the synthesis of N-substituted amides from nitriles and alcohols using propylphosphonic anhydride (T3P<sup>®</sup>) under solvent-free conditions
    作者:Hassan A. Swarup、Nagaraju Chaithra、Nagarakere C. Sandhya、Shobith Rangappa、Kempegowda Mantelingu、Kanchugarakoppal S. Rangappa
    DOI:10.1080/00397911.2019.1616761
    日期:2019.8.18
    developed from nitriles and alcohols using propylphosphonic anhydride (T3P®). This methodology is an alternate approach to the synthesis of amides via Ritter reaction, which is one of the classical methods for the synthesis of N-substituted amides from nitriles and alcohols. In this approach, first T3P® activates the alcohol which is then attacked by nitrile to form N-substituted amides. This methodology
    摘要 使用丙基膦酸酐 (T3P®) 从腈和醇中开发了构建 N-取代酰胺衍生物的新型便捷方法。该方法是通过 Ritter 反应合成酰胺的另一种方法,这是从腈和醇合成 N-取代酰胺的经典方法之一。在这种方法中,首先 T3P® 激活醇,然后被腈攻击形成 N-取代酰胺。该方法也适用于二苯甲基醚的合成。这个开发的协议是 T3P® 的新应用之一。图形概要
  • Sirtuin Inhibiting Compounds
    申请人:Sinclair David A
    公开号:US20090137681A1
    公开(公告)日:2009-05-28
    Provided herein are compositions and methods for treating or preventing cancer and autoimmune diseases. Compositions comprise a sirtuin inhibitory compound that decreases the activity of a sirtuin, such as SIRT1 or Sir2. Exemplary methods comprise contacting a cell or a molecule with a sirtuin inhibitory compound that decreases the activity of a sirtuin and thereby reduces the life span of a cell, kills the cell or renders it susceptible to certain cell stresses including radiation and chemotherapy. Other methods include treating pathogens expressing a sirtuin.
    本文提供了治疗或预防癌症和自身免疫疾病的组合物和方法。组合物包括抑制sirtuin的化合物,降低sirtuin的活性,如SIRT1或Sir2。示例方法包括将细胞或分子与抑制sirtuin的化合物接触,降低sirtuin的活性,从而缩短细胞的寿命,杀死细胞或使其对包括放射治疗和化疗在内的某些细胞应激变得敏感。其他方法包括治疗表达sirtuin的病原体。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐